Abstract:Transient receptor potential canonical channels (TRPCs) are calcium-permeable, nonselective cation channels. Human TRPC channels contain six functional members: TRPC1, and TRPC3-7, and they are widely distributed in many tissues. These channels are involved in numerous physiological processes, including regulating myogenic tone and blood pressure, endothelial barrier function regulation, hypoxic pulmonary vasoconstriction, neuronal function, and kidney function. They are also associated with several diseases, including traumatic brain injury, pathologic cardiac hypertrophy, atherosclerosis, the development of cancer, and diabetes. Specifically, gain-of-function mutations of the TRPC6 gene in humans cause focal segmental glomerular sclerosis (FSGS), a chronic kidney disease for which there is no effective treatment. Consequently, TRPC channels serve as drug targets for several diseases, including FSGS and anxiety. Recent developments in single-particle cryo-EM permit the determination of the structures of multiple TRPC channel members (TRPC3, TRPC4, TRPC5, and TRPC6) in multiple states at near-atomic resolutions. These structures demonstrate that TRPC channels are tetramers composed of two layers: The upper transmembrane domain (TMD) and the lower intracellular domain (ICD). The ICD layer consists of ankyrin repeat domains (ARD), linker helices domains (LHD), the TRP helix, and C terminal helices. The four protomers' voltage sensor-like domains (VSLD) and pore domains form the TMD layer. ICD has a bell-like shape with a large central chamber and caps below TMD. The structures reveal both the inhibitory calcium binding site in ICD and the activating calcium binding site in TMD. Calcium binding to the inhibitory site results in the closure of the ICD and the restriction of ion flow through the ICD, whereas calcium dissociation from the inhibitory site results in the opening of the ICD and the unrestricted flow of ions through the ICD. Calcium binding to the activating site increases its activity. Additionally, the binding pockets and binding poses of several small molecule modulators of TRPC channels are identified. Their binding sites are distributed across three distinct regions of TMD. One of the pockets partially overlaps the endogenous activating lipid diacylglycerol-binding site, while another partially overlaps the activating calcium-binding site. In conclusion, these structural findings combined with functional analysis, particularly site-directed mutagenesis data, reveal how intracellular calcium concentrations bi-directionally modulate the TRPC channel, how small molecules bind and tune the activity of TRPC channels, and how the gain-of-function mutations found in FSGS patients over-activate the intracellular calcium signaling of kidney podocytes via the TRPC6 channel in a positive feedback manner. These developments lay the groundwork for a more in-depth mechanistic dissection of TRPC channels. They would also facilitate the discovery of drugs that target TRPC channels to treat associated diseases.

Targeting Transient Receptor Potential Canonical Channels for Diseases of the Nervous System.

Canonical Transient Receptor Potential Channels and Their Link with Cardio/Cerebro-Vascular Diseases

Pathological function of transient receptor potential canonical 6 channel in key central nervous system diseases:its prospects as drug targets

Canonical Transient Receptor Potential (TRPC) Channels in Cardiovascular Pathology and their Modulators

Transient Receptor Potential Channels in the Healthy and Diseased Blood-Brain Barrier

Pathophysiological significance and modulation of the transient receptor potential canonical 3 ion channel

Contribution of TRPC Channels in Neuronal Excitotoxicity Associated With Neurodegenerative Disease and Ischemic Stroke

Roles of TRP Channels in Neurological Diseases

Functional roles of TRPC channels in the developing brain

The Role of Transient Receptor Potential Channels in Blood-Brain Barrier Dysfunction after Ischemic Stroke

TRP channels: Role in neurodegenerative diseases and therapeutic targets

Novel Targets for Stroke Therapy: Special Focus on TRPC Channels and TRPC6

Transient receptor potential canonical type 3 channels: Interactions, role and relevance - A vascular focus

Targeting Transient Receptor Potential Channels in Cardiometabolic Diseases and Myocardial Ischemia Reperfusion Injury.

Molecular Mechanism by Which TRPC6 Regulates Calcium Signaling and Neuroinflammation in the Onset and Development of Ischemic Stroke: A Review.

Canonical Transient Receptor Potential (TRPC) Channels in Nociception and Pathological Pain

Transient receptor potential channels in cardiac health and disease

Research progress on transient receptor potential melastatin 2 channel in nervous system diseases.

TRP (transient receptor potential) ion channel family: structures, biological functions and therapeutic interventions for diseases

Advances in the structural mechanism of TRPC channels

The TRPA1 channel in the cardiovascular system: promising features and challenges